Depending on the financial and exch rate interpretations as revealed in the latest formal report, Burt's figures might be as much as 15% lower.
Per BHP Dec 2023 H1 results presentation (p.10), the EBITDA margin for Ni was minus 24% on the avg realised price of USD18,602/T.
This means that the AISC came up to USD18,602 x 1.24 = USD23,066 (AUD34,600, at 1.5 exch rate).
Nickel West to be placed on C&M until 2027...
Raises a few questions:
- What intel does BHP now possess that is more accurate than the previous ones relied upon to invest $'Bs into Nickel West a few years ago?
- What does BHP know about the sustainability of Chindonesia's Ni mining beyond 2026?
- Is BHP watching/waiting and planning predatory moves on ARL in anticipation of impressive results from drilling out Kalpini's NiS tenements by 2027?
M&A possibility...
Might BHP make a move to just take us out at $10 per share by end-2025 (post-DFS)?
That's only $2B, is a much better Ni investment, and costs far less than what has been squandered to-date on Ni West with its less economic ore.
LT shs might also wait for $25 ps offer (equiv. to $5B NPV), but that will only eventuate with a fully operational mine, and a JORC-compliant NiS MRE to compensate for the 50% Goongarie laterite Ni ore to be owned by the JC. Earliest timeline for this achievement is likely 2027?
$10 or $25, at least LT shs have lucrative options on planning their CGT.
- Forums
- ASX - By Stock
- Pertinent market/industry news/articles
Depending on the financial and exch rate interpretations as...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ARL (ASX) to my watchlist
|
|||||
Last
52.0¢ |
Change
0.040(8.33%) |
Mkt cap ! $103.8M |
Open | High | Low | Value | Volume |
46.0¢ | 52.0¢ | 46.0¢ | $51.6K | 104.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 872 | 48.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
52.0¢ | 5497 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 872 | 0.480 |
2 | 5466 | 0.475 |
1 | 16000 | 0.460 |
2 | 60000 | 0.455 |
6 | 38100 | 0.450 |
Price($) | Vol. | No. |
---|---|---|
0.520 | 5497 | 1 |
0.530 | 50950 | 1 |
0.560 | 15000 | 1 |
0.595 | 6009 | 1 |
0.675 | 5313 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
ARL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online